Brazil Laboratory Developed Tests Market Size & Outlook

The laboratory developed tests market in Brazil is expected to reach a projected revenue of US$ 442.5 million by 2030. A compound annual growth rate of 5.6% is expected of Brazil laboratory developed tests market from 2024 to 2030.
Revenue, 2023 (US$M)
$303.1
Forecast, 2030 (US$M)
$442.5
CAGR, 2024 - 2030
5.6%
Report Coverage
Brazil

Brazil laboratory developed tests market, 2018-2030 (US$M)

Brazil

Brazil laboratory developed tests market highlights

  • The Brazil laboratory developed tests market generated a revenue of USD 303.1 million in 2023 and is expected to reach USD 442.5 million by 2030.
  • The Brazil market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
  • In terms of segment, molecular diagnostics was the largest revenue generating technology in 2023.
  • Immunoassays is the most lucrative technology segment registering the fastest growth during the forecast period.


Laboratory developed tests market data book summary

Market revenue in 2023USD 303.1 million
Market revenue in 2030USD 442.5 million
Growth rate5.6% (CAGR from 2023 to 2030)
Largest segmentMolecular diagnostics
Fastest growing segmentImmunoassays
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy
Key market players worldwideQuest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR


Other key industry trends

  • In terms of revenue, Brazil accounted for 2.5% of the global laboratory developed tests market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil laboratory developed tests market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 442.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Laboratory Developed Tests Market Scope

Laboratory developed tests market segmentation & scope
Immunoassays
Hematology and Coagulation
Molecular Diagnostics
Microbiology
Clinical Chemistry
Histology/Cytology
Flow Cytometry
Mass Spectroscopy
Others
Genetic Disorders/Inherited Disease
Infectious & Parasitic Diseases
Immunology
Endocrine
Nutritional & Metabolic Disease
Cardiology
Mental/Behavioral Disorder
Pediatrics-specific Testing
Hematology/General Blood Testing
Bodily Fluid Analysis
Toxicology
Other Diseases
Companion Diagnostics
Genomics Sequencing & Other

Laboratory Developed Tests Market Companies

Name Profile # Employees HQ Website

Brazil laboratory developed tests market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.


Molecular diagnostics was the largest segment with a revenue share of 23.46% in 2023. Horizon Databook has segmented the Brazil laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.


The prevalence of chronic diseases is high in the country due to the moderate standards of living, which increases the need for advanced diagnostic and treatment options. It has been found that infectious diseases are a major cause of death in Brazil. Hence, public and private organizations are undertaking initiatives to reduce the mortality rate.

For instance, in October 2018, Dasa entered into a partnership with Karius, Inc. to introduce Karius's next-generation sequencing-based infectious disease tests in Brazil. The technology will be available to multiple hospitals in the country to provide quick and accurate results. Several developments in the country would impact the Laboratory-Developed Tests (LDTs) market positively.

In addition, the developing biotechnology sector in Brazil is a key driving force for this market. Supportive government initiatives, such as the collaboration between the U.S. and Brazil on biomedical research to accelerate R&D on the diagnosis & treatment of infectious diseases, also drives the market growth.

Reasons to subscribe to Brazil laboratory developed tests market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil laboratory developed tests market databook

  • Our clientele includes a mix of laboratory developed tests market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into Brazil laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil laboratory developed tests market size, by technology, 2018-2030 (US$M)

Brazil Laboratory Developed Tests Market Outlook Share, 2023 & 2030 (US$M)

Brazil laboratory developed tests market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more